Syngene International Limited

Syngene International Limited is a leading global contract research organization (CRO) that provides comprehensive services in the field of drug discovery and development. Established in 1993, the company has built a strong reputation for its commitment to quality and innovation in the life sciences sector.

With a diverse portfolio of services, Syngene supports pharmaceutical, biotechnology, and agrochemical companies in their quest to bring new therapies to market. The company’s core activities include:

• Drug Discovery: Offering integrated solutions from target identification to preclinical development.
• Development Services: Providing formulation development, analytical testing, and stability studies.
• Manufacturing: Delivering high-quality active pharmaceutical ingredients (APIs) and intermediates.

Syngene operates state-of-the-art facilities equipped with advanced technologies, enabling it to meet the evolving needs of its clients. The company prides itself on its scientific expertise and a collaborative approach, working closely with clients to tailor solutions that align with their specific requirements.

Headquartered in Bangalore, India, Syngene has expanded its global footprint with offices and partnerships across the UK, US, and Europe. The company is dedicated to sustainability and ethical practices, ensuring that its operations contribute positively to society and the environment.

As a forward-thinking organization, Syngene is committed to leveraging cutting-edge research and development to drive innovation in healthcare. Its vision is to be a trusted partner in the life sciences industry, facilitating the development of safe and effective therapies that improve patient outcomes.